ZBH Zimmer Biomet Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZBH

Price (delayed)

$86.46

Market cap

$16.73B

P/E Ratio

22.34

Dividend/share

$0.96

EPS

$3.87

Enterprise value

$23.77B

?
Relative Growth: Rel. Growth: 67
Relative Strength: Rel. Strength: 27
Relative Valuation: Rel. Valuation: 63
Relative Profitability: Rel. Profitability: 60

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Highlights
ZBH's P/E is 54% lower than its 5-year quarterly average of 48.1 and 8% lower than its last 4 quarters average of 23.8
The revenue has grown by 9% YoY and by 2.2% from the previous quarter
The net income has declined by 17% year-on-year but it has grown by 8% since the previous quarter
The EPS has contracted by 15% YoY but it has grown by 9% from the previous quarter
ZBH's quick ratio is down by 41% YoY and by 16% QoQ
The debt has increased by 4.1% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.zimmerbiomet.com/
Peers: BSX COO SYK EW

Key stats

What are the main financial stats of ZBH

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
1.74%
1 week
4.4%
1 month
4.58%
1 year
-5.47%
YTD
-3.85%
QTD
-4.38%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$8.41B
Gross profit
$5.89B
Operating income
$1.18B
Net income
$761.1M
Gross margin
70%
Net margin
9.1%
The net margin has declined by 24% year-on-year but it has increased by 6% since the previous quarter
Zimmer Biomet Holdings's operating margin has decreased by 18% YoY but it has increased by 5% QoQ
The net income has declined by 17% year-on-year but it has grown by 8% since the previous quarter
Zimmer Biomet Holdings's operating income has decreased by 10% YoY but it has increased by 7% QoQ

Price vs fundamentals

How does ZBH's price correlate with its fundamentals

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
ZBH P/E details
P/E
22.34
P/B
1.33
P/S
2
EV/EBIT
19.83
EV/EBITDA
10.3
EV/Sales
2.83
ZBH's P/E is 54% lower than its 5-year quarterly average of 48.1 and 8% lower than its last 4 quarters average of 23.8
The EPS has contracted by 15% YoY but it has grown by 9% from the previous quarter
The stock's P/B is 31% below its 5-year quarterly average of 1.9 and 6% below its last 4 quarters average of 1.4
ZBH's equity is up by 2.2% year-on-year
ZBH's price to sales (P/S) is 40% lower than its 5-year quarterly average of 3.3 and 14% lower than its last 4 quarters average of 2.3
The revenue has grown by 9% YoY and by 2.2% from the previous quarter

Efficiency

How efficient is Zimmer Biomet Holdings business performance
The ROA has contracted by 21% YoY but it has grown by 6% from the previous quarter
The ROIC has decreased by 20% YoY but it has increased by 7% QoQ
Zimmer Biomet Holdings's return on equity has decreased by 18% YoY but it has increased by 7% QoQ
The ROS has contracted by 14% YoY but it has grown by 4.4% from the previous quarter

Dividends

What is ZBH's dividend history
Dividend details
DPS
$0.96
Dividend yield
1.11%
Payout ratio
24.8%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 126% higher than the total liabilities
ZBH's quick ratio is down by 41% YoY and by 16% QoQ
The current ratio has contracted by 29% YoY and by 13% from the previous quarter
The debt is 41% smaller than the equity
The debt has increased by 4.1% year-on-year
ZBH's equity is up by 2.2% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.